scholarly journals Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease

2001 ◽  
Vol 60 (1) ◽  
pp. 46-54 ◽  
Author(s):  
Emanuela Lovati ◽  
Alain Richard ◽  
Brigitte M. Frey ◽  
Felix J. Frey ◽  
Paolo Ferrari
Keyword(s):  
Renal Disease ◽  
Genetic Polymorphisms ◽  
End Stage Renal Disease ◽  
Renin Angiotensin Aldosterone System ◽  
Renin Angiotensin ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease

2005 ◽  
Vol 21 (4) ◽  
pp. 979-983 ◽  
Author(s):  
Monika Buraczynska ◽  
Piotr Ksiazek ◽  
Andrzej Drop ◽  
Wojciech Zaluska ◽  
Danuta Spasiewicz ◽  
...  
Keyword(s):  
Renal Disease ◽  
Genetic Polymorphisms ◽  
End Stage Renal Disease ◽  
Renin Angiotensin System ◽  
Angiotensin System ◽  
Renin Angiotensin ◽  
Stage Renal Disease ◽  
End Stage

Effects of Renin-Angiotensin-Aldosterone System Blockade in Patients with End-Stage Renal Disease

2016 ◽  
Vol 351 (3) ◽  
pp. 309-316 ◽  
Author(s):  
Teresa Slomka ◽  
Emily S. Lennon ◽  
Hina Akbar ◽  
Elvira O. Gosmanova ◽  
Syamal K. Bhattacharya ◽  
...  
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Renin Angiotensin Aldosterone System ◽  
Renin Angiotensin ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-(1–7) in End-Stage Renal Disease

2006 ◽  
Vol 60 (6) ◽  
pp. 734-739 ◽  
Author(s):  
Ana C Simões E Silva ◽  
José Silvério S Diniz ◽  
Regina M Pereira ◽  
Sérgio V Brant Pinheiro ◽  
Robson Augusto S Santos
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Renin Angiotensin System ◽  
Angiotensin System ◽  
Renin Angiotensin ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Genetic polymorphisms located in genes related to immune and inflammatory processes are associated with end-stage renal disease: a preliminary study

2012 ◽  
Vol 13 (1) ◽  
Author(s):  
Ma Angeles Jimenez-Sousa ◽  
Elisabeth López ◽  
Amanda Fernandez-Rodríguez ◽  
Eduardo Tamayo ◽  
Pablo Fernández-Navarro ◽  
...  
Keyword(s):  
Renal Disease ◽  
Genetic Polymorphisms ◽  
End Stage Renal Disease ◽  
Inflammatory Processes ◽  
Preliminary Study ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Diabetic nephropathy: what should cardiologist remember

2021 ◽  
Vol 23 (1) ◽  
pp. 20-24
Author(s):  
Natalia P. Trubitsyna ◽  
◽  
Natalia V. Zaitseva ◽  
Anastasia S. Severinа ◽  
◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Diabetic Nephropathy ◽  
Renal Replacement Therapy ◽  
Renal Disease ◽  
Replacement Therapy ◽  
End Stage Renal Disease ◽  
Kidney Diseases ◽  
Renin Angiotensin Aldosterone System ◽  
Stage Renal Disease ◽  
End Stage

Prevalence of diabetes mellitus (DM) progressively increases around the world. Diabetic nephropathy (DN) is significant reason of end-stage renal disease and it is associated with high risk of cardiovascular disease and mortality. Necessity of expensive renal replacement therapy for patients with prominent vascular diabetic complications and end-stage renal disease has significant socio-economic impact. DM, as a one of leading causes of kidney diseases, competes for stricted resources of public health. Renal replacement therapy in patients with DM does not solve the whole problem, because survival of such patients is low, comparing with another kidney diseases, first of all because of cardiovascular diseases. Good control of glycaemia, blood pressure and cholesterol level and prescription of renin-angiotensin-aldosterone system inhibitors and statins decrease cardiovascular risk and slow down DN progression, as it was shown in many clinical trials. So patients with DM and DN should receive complex therapy for risk reduction of kidney disease and cardiovascular disorders progression. Keywords: diabetes mellitus type 2, diabetic nephropathy, nephroprotection, cardioprotection, SGLT-2 inhibitors, GLP-1 agonists, renin-angiotensin-aldosterone system For citation: Trubitsyna NP, Zaitseva NV, Severinа AS. Diabetic nephropathy: what should cardiologist remember. Consilium Medicum. 2021; 23 (1): 20–24. DOI: 10.26442/20751753.2021.1.200712

scholarly journals Non-association of VEGF genetic polymorphisms in promoter – 5′ UTR with end-stage renal disease

2006 ◽  
Vol 21 (4) ◽  
pp. 1124-1125
Author(s):  
Kent Doi ◽  
Eisei Noiri ◽  
Toshiro Fujita ◽  
Katsushi Tokunaga
Keyword(s):  
Renal Disease ◽  
Genetic Polymorphisms ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document